Congratulations to Salford Royal’s neurology research team, who recruited the first UK patient to the Ensemble trial for people with multiple sclerosis.
The trial is working with patients who have been diagnosed with relapsing remitting multiple sclerosis within the last three years but haven’t yet been treated for it. Patients who are recruited to the study will be given intravenous infusions of a drug called Ocrelizumab every six months – this is a treatment targeting particular cells which are believed to play a critical role in multiple sclerosis.
Dr Nazar Sharaf is the Principal Investigator for the Roche Products study at Salford Royal and after recruiting the first patient in the UK, the research team quickly went on to achieve its five-patient recruitment target and further patients before Christmas as agreed by the sponsor.
Dr Sharaf is on the right of the picture, with Research Nurses Elaine Shields and Sian Corbett.